Immunotherapy in resistant cancer: from the bench to the clinic

A new textbook entitled ‘Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives’ explains immunotherapies for different types of cancer, helping users carry out research or create alternatives for drug development.

This book is a volume in the Sensitizing Agents for Cancer Resistant to Cell Mediated Immunotherapy series, which provides high-level knowledge on detailed mechanisms of actions and biological interactions of different immune drugs to offer researchers and clinicians cutting-edge therapies to overcome drug resistance.

Topics discussed include the relationship between immunotherapy and macrophages, immune checkpoints in different types of cancer, immune cocktails in solid tumours, and immune phenotyping.

Click here for more details.

Upcoming Events

Hands-free, safe and remote dissection: a Menarini webinar

Online
4 March 2021

COVID-19 - The Infection Challenging the World

Online
11-14 May 2021

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Upcoming Events

Hands-free, safe and remote dissection: a Menarini webinar

Online
4 March 2021

COVID-19 - The Infection Challenging the World

Online
11-14 May 2021

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022